-transparent.png){kind=logo}
We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantation since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.
Related Publications
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
January 1976,
Postgraduate medical journal,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
January 1977,
Scandinavian journal of urology and nephrology. Supplementum,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
September 1969,
Surgery,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
April 1970,
Helvetica chirurgica acta,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
February 1968,
Annals of internal medicine,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
March 2007,
Transplantation,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
March 1973,
Transplantation proceedings,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
July 1967,
Science (New York, N.Y.),
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
March 1971,
Transplantation proceedings,
C W Putnam, and
R H Bell, and
R W Beart, and
J T Anderson, and
R Weil
August 1992,
Transplantation proceedings,
